Transplantation for MDS in the Elderly: More Evidence, or More Bias?

被引：5
作者：
Cutler, Corey [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 09期
关键词：
STEM-CELL TRANSPLANTATION; UNRELATED DONORS;
D O I：
10.1016/j.bbmt.2012.06.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1320 / 1321
页数：2
相关论文
共 7 条
  • [1] Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival
    de Witte, Theo
    Brand, Ronald
    van Biezen, Anja
    Mufti, Ghulam
    Ruutu, Tapani
    Finke, Juergen
    von dem Borne, Peter
    Vitek, Antonin
    Delforge, Michel
    Alessandrino, Paolo
    Harlahakis, Nicolas
    Russell, Nigel
    Martino, Roberto
    Verdonck, Leo
    Kroeger, Nicholas
    Niederwieser, Dietger
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (06) : 627 - 636
  • [2] Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
    Deeg, HJ
    Storer, B
    Slattery, JT
    Anasetti, C
    Doney, KC
    Hansen, JA
    Kiem, HP
    Martin, PJ
    Petersdorf, E
    Radich, JP
    Sanders, JE
    Shulman, HM
    Warren, EH
    Witherspoon, RP
    Bryant, EM
    Chauncey, TR
    Getzendaner, L
    Storb, R
    Appelbaum, FR
    [J]. BLOOD, 2002, 100 (04) : 1201 - 1207
  • [3] Koreth J, 2011, ASH ANN M
  • [4] Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age
    Koreth, John
    Aldridge, Julie
    Kim, Haesook T.
    Alyea, Edwin P., III
    Cutler, Corey
    Armand, Philippe
    Ritz, Jerome
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 792 - 800
  • [5] Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome
    Kroeger, Nicolaus
    [J]. BLOOD, 2012, 119 (24) : 5632 - 5639
  • [6] Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
    McClune, Brian L.
    Weisdorf, Daniel J.
    Pedersen, Tanya L.
    Tunes da Silva, Gisela
    Tallman, Martin S.
    Sierra, Jorge
    DiPersio, John
    Keating, Armand
    Gale, Robert P.
    George, Biju
    Gupta, Vikas
    Hahn, Theresa
    Isola, Luis
    Jagasia, Madan
    Lazarus, Hillard
    Marks, David
    Maziarz, Richard
    Waller, Edmund K.
    Bredeson, Chris
    Giralt, Sergio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1878 - 1887
  • [7] Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine
    Platzbecker, Uwe
    Schetelig, Johannes
    Finke, Juergen
    Trenschel, Rudolf
    Scott, Bart L.
    Kobbe, Guido
    Schaefer-Eckart, Kerstin
    Bornhaeuser, Martin
    Itzykson, Raphael
    Germing, Ulrich
    Beelen, Dietrich
    Ehninger, Gerhard
    Fenaux, Pierre
    Deeg, H. Joachim
    Ades, Lionel
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) : 1415 - 1421
1